By Josh Beckerman

Johnson & Johnson (JNJ) said Wednesday that a unique contact lens that quickly adjusts to changing light conditions has received a medical device license in Canada.

Acuvue Oasys with Transitions, a two-week reusable lens, will be commercially available in the first half of 2019. The lens, developed with EssilorLuxottica SA (EL.FR, ELSOY) unit Transitions Optical, received U.S. Food and Drug Administration approval in April.

The lens reduces bright light, filters blue light and blocks ultraviolet rays. On Tuesday, Johnson & Johnson announced favorable data from two new studies of photochromic lenses, citing benefits like improved driving performance.

Write to Josh Beckerman at josh.beckerman@wsj.com

(END) Dow Jones Newswires

November 07, 2018 13:33 ET (18:33 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
Essilorluxottica (EU:EL)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Essilorluxottica Charts.
Essilorluxottica (EU:EL)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Essilorluxottica Charts.